Inhibiting the kynurenine pathway in spinal cord injury: Multiple therapeutic potentials?

by Kelly R Jacobs, David B Lovejoy
Published 2018-01-01

Metabolomic Biomarkers of Multiple Sclerosis: A Systematic Review

by Lachlan Porter, Alireza Shoushtarizadeh, George A. Jelinek, Chelsea R. Brown, Chai K. Lim, Alysha M. de Livera, Kelly R. Jacobs, Tracey J. Weiland
Published 2020-12-01

Effects of Tryptophan Supplementation and Exercise on the Fate of Kynurenine Metabolites in Mice and Humans

by Paula Valente-Silva, Igor Cervenka, Duarte M. S. Ferreira, Jorge C. Correia, Sebastian Edman, Oscar Horwath, Benjamin Heng, Sharron Chow, Kelly R. Jacobs, Gilles J. Guillemin, Eva Blomstrand, Jorge L. Ruas
Published 2021-08-01

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

by Pratishtha Chatterjee, Henrik Zetterberg, Kathryn Goozee, Chai K. Lim, Kelly R. Jacobs, Nicholas J. Ashton, Abdul Hye, Steve Pedrini, Hamid R. Sohrabi, Tejal Shah, Prita R. Asih, Preeti Dave, Kaikai Shen, Kevin Taddei, David B. Lovejoy, Gilles J. Guillemin, Kaj Blennow, Ralph N. Martins
Published 2019-10-01

Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β

by Marcela Cespedes, Kelly R. Jacobs, Paul Maruff, Alan Rembach, Christopher J. Fowler, Brett Trounson, Kelly K. Pertile, Rebecca L. Rumble, Stephanie R. Rainey-Smithe, Christopher C. Rowe, Victor L. Villemagne, Pierrick Bourgeat, Chai K. Lim, Pratishtha Chatterjee, Ralph N. Martins, Arne Ittner, Colin L. Masters, James D. Doecke, Gilles J. Guillemin, David B. Lovejoy
Published 2022-09-01